Integrative Multiomics Profiling of Mouse Hippocampus Reveals Transcriptional Upregulation of Interferon-Stimulated Genes Through PU.1 Regulator in Microglial Activation Induced by Chronic Cerebral Hypoperfusion

Abstract

Chronic cerebral hypoperfusion (CCH) is a significant factor that accelerates cognitive deterioration, yet the mechanisms of hippocampal microglial activation in this context remain unclear. Using an integrative multiomics approach, we investigated the transcriptional and epigenomic landscape of microglial activation in a mouse model of CCH induced by bilateral common carotid artery stenosis. Behavioral assessments revealed cognitive impairments, while neuropathological analysis confirmed hippocampal damage. Proteomic and transcriptomic profiling uncovered significant upregulation of stress and inflammatory pathways, particularly the interferon (IFN) signaling cascade. Epigenomic analysis identified regions of open chromatin, suggesting active transcriptional regulation driven by the transcription factor (TF) PU.1. ChIP-nexus analysis further confirmed that PU.1 directly modulates the expression of IFN-stimulated genes (ISGs), which are pivotal in regulating microglial activation. Our findings demonstrate that PU.1 serves as a key regulator of the IFN-driven microglial response during CCH, mediated by enhanced chromatin accessibility and transcriptional activation of ISGs. This study highlights the critical role of PU.1 in microglial-mediated neuroinflammation and offers potential therapeutic targets for mitigating hippocampal damage associated with chronic cerebral ischemia.

Keywords

chronic cerebral hypoperfusion (CCH) / interferon signaling / microglial activation / multiomics analysis / PU.1

References

[1] V. Calabrese, J. Giordano, A. Signorile, et al., “Major Pathogenic Mechanisms in Vascular Dementia: Roles of Cellular Stress Response and Hormesis in Neuroprotection,” Journal of Neuroscience Research 94, no. 12 (2016): 1588-1603.

[2] W. Li, D. Wei, J. Liang, X. Xie, K. Song, and L. Huang, “Comprehensive Evaluation of White Matter Damage and Neuron Death and Whole-Transcriptome Analysis of Rats with Chronic Cerebral Hypoperfusion,” Frontiers in Cellular Neuroscience 13 (2019): 310.

[3] W. Xu, Q. Bai, Q. Dong, M. Guo, and M. Cui, “Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment,” Frontiers in Cellular Neuroscience 16 (2022): 870674.

[4] V. Rajeev, Y. L. Chai, L. Poh, et al., “Chronic Cerebral Hypoperfusion: A Critical Feature in Unravelling the Etiology of Vascular Cognitive Impairment,” Acta Neuropathologica Communications 11, no. 1 (2023): 93.

[5] J. I. Lee, J. S. Lim, J. H. Hong, et al., “Selective Neurodegeneration of the Hippocampus Caused by Chronic Cerebral Hypoperfusion: F-18 FDG PET Study in Rats,” PLoS ONE 17, no. 2 (2022): e0262224.

[6] V. Rajeev, D. Y. Fann, Q. N. Dinh, et al., “Pathophysiology of Blood Brain Barrier Dysfunction During Chronic Cerebral Hypoperfusion in Vascular Cognitive Impairment,” Theranostics 12, no. 4 (2022): 1639-1658.

[7] L. Poh, W. L. Sim, D.-G. Jo, et al., “The Role of Inflammasomes in Vascular Cognitive Impairment,” Molecular Neurodegeneration 17, no. 1 (2022): 4.

[8] J. Miyanohara, M. Kakae, K. Nagayasu, et al., “TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion,” Journal of Neuroscience 38, no. 14 (2018): 3520-3533.

[9] L. Poh, D. Y. Fann, P. Wong, et al., “AIM2 inflammasome Mediates Hallmark Neuropathological Alterations and Cognitive Impairment in a Mouse Model of Vascular Dementia,” Molecular Psychiatry 26, no. 8 (2021): 4544-4560.

[10] Y. Liao, J. Cheng, X. Kong, et al., “HDAC3 inhibition Ameliorates Ischemia/Reperfusion-induced Brain Injury by Regulating the Microglial cGAS-STING Pathway,” Theranostics 10, no. 21 (2020): 9644-9662.

[11] Z. Zhang, Z. Guo, P. Jin, et al., “Transcriptome Profiling of Hippocampus after Cerebral Hypoperfusion in Mice,” Journal of Molecular Neuroscience 73, no. 6 (2023): 423-436.

[12] K. Vandereyken, A. Sifrim, B. Thienpont, and T. Voet, “Methods and Applications for Single-cell and Spatial Multi-omics,” Nature Reviews Genetics 24, no. 8 (2023): 494-515.

[13] J. Rutledge, H. Oh, and T. Wyss-Coray, “Measuring Biological Age Using Omics Data,” Nature Reviews Genetics 23, no. 12 (2022): 715-727.

[14] F. Yan, D. R. Powell, D. J. Curtis, and N. C. Wong, “From Reads to Insight: A Hitchhiker's Guide to ATAC-seq Data Analysis,” Genome Biology 21, no. 1 (2020): 22.

[15] X. Jin, Y. Mei, P. Yang, et al., “Prioritization of Therapeutic Targets for Cancers Using Integrative Multi-omics Analysis,” Human Genomics 18, no. 1 (2024): 42.

[16] A. Baysoy, Z. Bai, R. Satija, and R. Fan, “The Technological Landscape and Applications of Single-cell Multi-omics,” Nature Reviews Molecular Cell Biology 24, no. 10 (2023): 695-713.

[17] X. Li, Y. Li, Y. Jin, et al., “Transcriptional and Epigenetic Decoding of the Microglial Aging Process,” Nature Aging 3, no. 10 (2023): 1288-1311.

[18] M. C. Blaser, S. Kraler, T. F. Lüscher, and E. Aikawa, “Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis,” Circulation Research 128, no. 9 (2021): 1371-1397.

[19] Y. Zhang, J. Li, Y. Zhao, et al., “Arresting the Bad Seed: HDAC3 Regulates Proliferation of Different Microglia After Ischemic Stroke,” Science Advances 10, no. 10 (2024): eade6900.

[20] Z. Zhang, Z. Guo, Z. Tu, et al., “Cortex-specific Transcriptome Profiling Reveals Upregulation of Interferon-regulated Genes After Deeper Cerebral Hypoperfusion in Mice,” Frontiers in Physiology 14 (2023): 1056354.

[21] C.-H. Du, Y.-D. Wu, K. Yang, et al., “Apoptosis-resistant Megakaryocytes Produce Large and Hyperreactive Platelets in Response to Radiation Injury,” Military Medical Research 10, no. 1 (2023): 66.

[22] A. Zeisel, A. B. Muñoz-Manchado, S. Codeluppi, et al., “Brain Structure. Cell Types in the Mouse Cortex and Hippocampus Revealed by Single-cell RNA-seq,” Science 347, no. 6226 (2015): 1138-1142.

[23] Z. Zhang, P. Jin, Z. Guo, et al., “Integrated Analysis of Chromatin and Transcriptomic Profiling Identifies PU.1 as a Core Regulatory Factor in Microglial Activation Induced by Chronic Cerebral Hypoperfusion,” Molecular Neurobiology 61, no. 5 (2024): 2569-2589.

[24] Y. Xie, X. Zhang, P. Xu, et al., “Aberrant Oligodendroglial LDL Receptor Orchestrates Demyelination in Chronic Cerebral Ischemia,” Journal of Clinical Investigation 131, no. 1 (2021): e128114.

[25] M. Kakae, H. Nakajima, S. Tobori, et al., “The Astrocytic TRPA1 Channel Mediates an Intrinsic Protective Response to Vascular Cognitive Impairment via LIF Production,” Science Advances 9, no. 29 (2023): eadh0102.

[26] Q. Liu, M. I. H. Bhuiyan, R. Liu, et al., “Attenuating Vascular Stenosis-induced Astrogliosis Preserves White Matter Integrity and Cognitive Function,” Journal of Neuroinflammation 18, no. 1 (2021): 187.

[27] Z. Zhou, Y. Ma, T. Xu, et al., “Deeper Cerebral Hypoperfusion Leads to Spatial Cognitive Impairment in Mice,” Stroke and Vascular Neurology 7, no. 6 (2022): 527-533.

[28] K. Miki, S. Ishibashi, L. Sun, et al., “Intensity of Chronic Cerebral Hypoperfusion Determines White/Gray Matter Injury and Cognitive/Motor Dysfunction in Mice,” Journal of Neuroscience Research 87, no. 5 (2009): 1270-1281.

[29] H. Kim, J. S. Seo, S.-Y. Lee, et al., “AIM2 inflammasome Contributes to Brain Injury and Chronic Post-stroke Cognitive Impairment in Mice,” Brain, Behavior, and Immunity 87 (2020): 765-776.

[30] L. E. Fritsch, J. Ju, E. K. Gudenschwager Basso, et al., “Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury,” Frontiers in Molecular Neuroscience 15 (2022): 852243.

[31] L. M. Wangler, C. E. Bray, J. M. Packer, et al., “Amplified Gliosis and Interferon-Associated Inflammation in the Aging Brain Following Diffuse Traumatic Brain Injury,” The Journal of Neuroscience: the Official Journal of the Society For Neuroscience 42, no. 48 (2022): 9082-9096.

[32] B. P. Todd, M. S. Chimenti, Z. Luo, P. J. Ferguson, A. G. Bassuk, and E. A. Newell, “Traumatic Brain Injury Results in Unique Microglial and Astrocyte Transcriptomes Enriched for Type I Interferon Response,” Journal of Neuroinflammation 18, no. 1 (2021): 151.

[33] A. McDonough, R. V. Lee, S. Noor, et al., “Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia,” The Journal of Neuroscience: the Official Journal of the Society For Neuroscience 37, no. 34 (2017): 8292-8308.

[34] S. I. Machlovi, S. M. Neuner, B. M. Hemmer, et al., “APOE4 confers Transcriptomic and Functional Alterations to Primary Mouse Microglia,” Neurobiology of Disease 164 (2022): 105615.

[35] E. Harmon, A. Doan, J. Bautista-Garrido, J. E. Jung, S. P. Marrelli, and G. S. Kim, “Increased Expression of Interferon-Induced Transmembrane 3 (IFITM3) in Stroke and Other Inflammatory Conditions in the Brain,” International Journal of Molecular Sciences 23, no. 16 (2022): 8885.

[36] Q. Miao, M. Ge, and L. Huang, “Up-regulation of GBP2 Is Associated With Neuronal Apoptosis in Rat Brain Cortex following Traumatic Brain Injury,” Neurochemical Research 42, no. 5 (2017): 1515-1523.

[37] X. Xiao, P. Bai, S. Cao, et al., “Integrated Bioinformatics Analysis for the Identification of Key Molecules and Pathways in the Hippocampus of Rats after Traumatic Brain Injury,” Neurochemical Research 45, no. 4 (2020): 928-939.

[38] H. Tang, C. Shao, X. Wang, et al., “6-Gingerol Attenuates Subarachnoid Hemorrhage-induced Early Brain Injury via GBP2/PI3K/AKT Pathway in the Rat Model,” Frontiers in Pharmacology 13 (2022): 882121.

[39] T. Goldmann, P. Wieghofer, M. J. C. Jordão, et al., “Origin, Fate and Dynamics of Macrophages at central Nervous System Interfaces,” Nature Immunology 17, no. 7 (2016): 797-805.

[40] A. M. Smith, H. M. Gibbons, R. L. Oldfield, et al., “The Transcription Factor PU.1 Is Critical for Viability and Function of human Brain Microglia,” Glia 61, no. 6 (2013): 929-942.

[41] A. Sudwarts, S. Ramesha, T. Gao, et al., “BIN1 is a Key Regulator of Proinflammatory and Neurodegeneration-related Activation in Microglia,” Molecular Neurodegeneration 17, no. 1 (2022): 33.

[42] H. O. Dikmen, M. Hemmerich, A. Lewen, J.-O. Hollnagel, B. Chausse, and O. Kann, “GM-CSF Induces Noninflammatory Proliferation of Microglia and Disturbs Electrical Neuronal Network Rhythms in Situ,” Journal of Neuroinflammation 17, no. 1 (2020): 235.

[43] B. Cakir, Y. Tanaka, F. R. Kiral, et al., “Expression of the Transcription Factor PU.1 Induces the Generation of Microglia-Like Cells in human Cortical Organoids,” Nature Communications 13, no. 1 (2022): 430.

[44] Q. G. Eichbaum, R. Iyer, D. P. Raveh, C. Mathieu, and R. A. Ezekowitz, “Restriction of Interferon Gamma Responsiveness and Basal Expression of the Myeloid human Fc Gamma R1b Gene Is Mediated by a Functional PU.1 Site and a Transcription Initiator Consensus,” Journal of Experimental Medicine 179, no. 6 (1994): 1985-1996.

[45] E. A. Eklund, A. Jalava, and R. Kakar, “PU.1, Interferon Regulatory Factor 1, and Interferon Consensus Sequence-binding Protein Cooperate to Increase gp91(phox) Expression,” Journal of Biological Chemistry 273, no. 22 (1998): 13957-13965.

[46] J. Shao, Y. Meng, K. Yuan, et al., “RU.521 Mitigates Subarachnoid Hemorrhage-induced Brain Injury via Regulating Microglial Polarization and Neuroinflammation Mediated by the cGAS/STING/NF-κB Pathway,” Cell Communication and Signaling 21, no. 1 (2023): 264.

[47] T. Sen, P. Saha, R. Gupta, et al., “Aberrant ER Stress Induced Neuronal-IFNβ Elicits White Matter Injury due to Microglial Activation and T-Cell Infiltration After TBI,” The Journal of Neuroscience: the Official Journal of the Society For Neuroscience 40, no. 2 (2020): 424-446.

[48] X. Ma, W. Wu, W. Liang, Y. Takahashi, J. Cai, and J.-X. Ma, “Modulation of cGAS-STING Signaling by PPARα in a Mouse Model of Ischemia-induced Retinopathy,” Proceedings of the National Academy of Sciences of the United States of America 119, no. 48 (2022): e2208934119.

[49] W. Li, N. Shen, L. Kong, et al., “STING Mediates Microglial Pyroptosis via Interaction With NLRP3 in Cerebral Ischaemic Stroke,” Stroke and Vascular Neurology 9, no. 2 (2024): 153-164.

[50] L. Kong, W. Li, E. Chang, et al., “mtDNA-STING Axis Mediates Microglial Polarization via IRF3/NF-κB Signaling after Ischemic Stroke,” Frontiers in Immunology 13 (2022): 860977.

[51] C. Wu, S. Zhang, H. Sun, et al., “STING Inhibition Suppresses Microglia-mediated Synapses Engulfment and Alleviates Motor Functional Deficits After Stroke,” Journal of Neuroinflammation 21, no. 1 (2024): 86.

[52] S. Deng, S. Shu, L. Zhai, et al., “Optogenetic Stimulation of mPFC Alleviates White Matter Injury-Related Cognitive Decline After Chronic Ischemia Through Adaptive Myelination,” Advanced Science (Weinheim) 10, no. 5 (2023): e2202976.

[53] C. V. Vorhees and M. T. Williams, “Morris Water Maze: Procedures for Assessing Spatial and Related Forms of Learning and Memory,” Nature Protocols 1, no. 2 (2006): 848-858.

[54] N. Tominaga, N. Kosaka, M. Ono, et al., “Brain Metastatic Cancer Cells Release microRNA-181c-containing Extracellular Vesicles Capable of Destructing Blood-brain Barrier,” Nature Communications 6 (2015): 6716.

[55] S.-Z. Zhang, Q.-Q. Wang, Q.-Q. Yang, et al., “NG2 glia Regulate Brain Innate Immunity via TGF-β2/TGFBR2 Axis,” BMC Medicine [Electronic Resource] 17, no. 1 (2019): 204.

[56] M. Zhang, H. Huang, J. Li, and Q. Wu, “ZNF143 deletion Alters Enhancer/Promoter Looping and CTCF/Cohesin Geometry,” Cell Reports 43, no. 1 (2024): 113663.

[57] R. Aebersold and M. Mann, “Mass-spectrometric Exploration of Proteome Structure and Function,” Nature 537, no. 7620 (2016): 347-355.

[58] C. Lazar, L. Gatto, M. Ferro, C. Bruley, and T. Burger, “Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies,” Journal of Proteome Research 15, no. 4 (2016): 1116-1125.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.